| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |